title: Cardiovascular consequences of recombinant DNA technology: interleukin-2.
authors.affiliation: St. Elizabeth's Hospital, Boston, Massachusetts.
authors.forename: J M
authors.initials: JM
authors.lastname: Isner
authors.forename: W A
authors.initials: WA
authors.lastname: Dietz
mesh_terms: D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007376:Interleukin-2 / Q000009:adverse effects*; D007694:Killer Cells, Natural / Q000276:immunology; D011669:Pulmonary Wedge Pressure; D012772:Shock, Septic / Q000503:physiopathology
chemical_list: D007376:Interleukin-2